Nicola Martinelli Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2012	Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.
8/2010	Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola Martinelli Research Topics

Disease

31	Coronary Artery Disease (Coronary Atherosclerosis) 08/2022 - 05/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2005
10	Myocardial Infarction 01/2016 - 09/2004
7	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2009
7	Atherosclerosis 01/2023 - 12/2003
6	Inflammation (Inflammations) 01/2023 - 03/2007
6	Hypertension (High Blood Pressure) 01/2021 - 09/2007
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 12/2003
4	Neoplasms (Cancer) 01/2024 - 03/2013
4	Asthma (Bronchial Asthma) 03/2023 - 04/2003
4	Chronic Urticaria 01/2011 - 09/2004
3	Cholangiocarcinoma 01/2024 - 01/2016
3	Hemophilia A (Haemophilia) 03/2023 - 01/2019
3	Rheumatoid Arthritis 01/2021 - 11/2005
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 07/2017
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 02/2014
3	Hyperhomocysteinemia 02/2011 - 05/2003
3	Pruritus (Itching) 01/2011 - 09/2004
2	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2017
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2016
2	Thrombosis (Thrombus) 01/2023 - 06/2010
2	Essential Hypertension 01/2023 - 01/2021
2	Disease Susceptibility (Diathesis) 11/2022 - 02/2019
2	Atrial Fibrillation 01/2021 - 01/2020
2	Stroke (Strokes) 01/2021 - 01/2020
2	Infections 12/2015 - 01/2015
2	Carcinogenesis 03/2013 - 06/2010
2	Iron Overload 01/2012 - 11/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 08/2010
2	Systemic Scleroderma (Systemic Sclerosis) 07/2009 - 02/2003
2	Peripheral Arterial Disease 07/2009 - 09/2007
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2009 - 01/2006
2	Hypersensitivity (Allergy) 01/2006 - 11/2005
2	Urticaria (Hives) 11/2005 - 04/2003
1	Adenoma (Adenomas) 01/2023
1	Hyperaldosteronism (Conn Syndrome) 01/2023
1	Pneumonia (Pneumonitis) 11/2022
1	COVID-19 11/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 08/2022
1	Dyslipidemias (Dyslipidemia) 08/2022
1	Ischemic Stroke 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021

Drug/Important Bio-Agent (IBA)

12	LipidsIBA 08/2022 - 02/2005
9	Apolipoprotein C-IIIIBA 01/2023 - 12/2003
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2003
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2013
7	C-Reactive ProteinIBA 11/2022 - 12/2003
5	Factor VIIa (Activated Factor VII)IBA 01/2024 - 09/2004
5	Lipoproteins (Lipoprotein)IBA 01/2023 - 12/2003
5	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2006
5	HepcidinsIBA 01/2014 - 11/2009
5	IronIBA 05/2013 - 08/2005
4	Factor VIII (Coagulation Factor VIII)IBA 03/2023 - 12/2010
3	Thromboplastin (Tissue Factor)IBA 01/2024 - 02/2019
3	Messenger RNA (mRNA)IBA 01/2024 - 10/2020
3	AntithrombinsIBA 01/2024 - 01/2020
3	ApolipoproteinsIBA 01/2023 - 05/2009
3	LDL CholesterolIBA 08/2022 - 12/2013
3	CoagulantsIBA 01/2021 - 12/2010
3	AntibodiesIBA 01/2021 - 12/2003
3	AnticoagulantsIBA 01/2021 - 01/2019
3	VaccinesIBA 01/2018 - 08/2013
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 02/2005
3	Aryldialkylphosphatase (Paraoxonase)IBA 05/2013 - 01/2009
3	Folic Acid (Vitamin M)FDA LinkGeneric 03/2013 - 05/2003
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2009 - 02/2005
3	Tacrolimus (Prograf)FDA LinkGeneric 03/2008 - 09/2006
3	Ointments (Pastes)IBA 03/2008 - 09/2006
2	Fibrinogen (Factor I)FDA Link 11/2022 - 06/2004
2	AutoantibodiesIBA 01/2021 - 01/2006
2	SteroidsIBA 01/2021 - 11/2006
2	AntigensIBA 01/2021 - 01/2011
2	Myristic Acid (Tetradecanoic Acid)IBA 10/2020 - 01/2018
2	Thrombin FDA Link 02/2019 - 07/2017
2	CholesterolIBA 01/2018 - 12/2013
2	CarbonIBA 01/2017 - 01/2016
2	NucleotidesIBA 01/2017 - 01/2016
2	Particulate MatterIBA 06/2013 - 01/2012
2	Factor VII (Proconvertin)IBA 03/2012 - 09/2004
2	Insulin (Novolin)FDA Link 01/2012 - 02/2005
2	VitaminsIBA 02/2011 - 06/2004
2	EnzymesIBA 01/2011 - 01/2009
2	Peptides (Polypeptides)IBA 11/2009 - 11/2005
2	Arachidonic Acid (Vitamin F)IBA 10/2008 - 04/2008
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 03/2008 - 09/2006
2	Infliximab (Remicade)FDA Link 01/2006 - 11/2005
2	Antinuclear AntibodiesIBA 01/2006 - 11/2005
1	AldosteroneIBA 01/2023
1	Apolipoproteins E (ApoE)IBA 08/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2022
1	Apolipoproteins B (ApoB)IBA 08/2022
1	Asialoglycoprotein ReceptorIBA 01/2022
1	Uric Acid (Urate)IBA 05/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	Protein-Arginine Deiminase Type 4IBA 01/2021
1	Peptide LibraryIBA 01/2021

Therapy/Procedure

8	Therapeutics 03/2023 - 09/2004
2	Secondary Prevention 05/2021 - 10/2020
1	Precision Medicine 03/2023